Contact
searchSearch
HMP Global
Login
Dr Joshua Richter, Associate Professor of Medicine, Tisch Cancer Institute
Videos
Analyzing the Effect of Immune Therapies on Infection in Patients With Multiple Myeloma
12/05/2022
Dr Joshua Richter, associate professor of medicine at Tisch Cancer Institute, discusses his presentation on the effects of immune therapies on infection in patients with multiple myeloma.
Dr Joshua Richter, associate professor of medicine at Tisch Cancer Institute, discusses his presentation on the effects of immune therapies on infection in patients with multiple myeloma.
Dr Joshua Richter, associate...
12/05/2022
Journal of Clinical Pathways
News
Evolution of Diagnosis and Treatment of SCLC Over the Last 20 Years
10/22/2021
Study findings suggest that changes in the clinical management of patients with SCLC over the last 20 years have not had a significant impact on survival.
Study findings suggest that changes in the clinical management of patients with SCLC over the last 20 years have not had a significant impact on survival.
Study findings suggest that...
10/22/2021
Journal of Clinical Pathways
Ethan Sokol, PhD
Videos
Real-World Outcomes of HR-Positive HER2-Negative Metastatic Breast Cancer Treated With ICIs
10/21/2021
Ethan Sokol, PhD, discusses real-world time-to-treatment-discontinuation for patients with high tumor mutational burden HR-positive and HER2-negative breast cancer who were treated with immune checkpoint inhibitors.
Ethan Sokol, PhD, discusses real-world time-to-treatment-discontinuation for patients with high tumor mutational burden HR-positive and HER2-negative breast cancer who were treated with immune checkpoint inhibitors.
Ethan Sokol, PhD, discusses...
10/21/2021
Journal of Clinical Pathways
Geoffrey Oxnard, MD
Videos
Real-World Testing and Treatment Patterns in Advanced NSCLC
10/18/2021
Geoffrey Oxnard, MD, compares treatment regimens for patients with advanced NSCLC prior to receipt of comprehensive genomic profiling vs after receipt of comprehensive genomic profiling in the real-world setting.
Geoffrey Oxnard, MD, compares treatment regimens for patients with advanced NSCLC prior to receipt of comprehensive genomic profiling vs after receipt of comprehensive genomic profiling in the real-world setting.
Geoffrey Oxnard, MD, compares...
10/18/2021
Journal of Clinical Pathways
Patrick Connor Johnson, MD
Videos
Physician Survey Reveals Key Attributes for Third-Line Treatment Selection for DLBCL
10/18/2021
Patrick Connor Johnson, MD, discusses study results on physician perspectives regarding key attributes for selecting third-line treatment for DLBCL.
Patrick Connor Johnson, MD, discusses study results on physician perspectives regarding key attributes for selecting third-line treatment for DLBCL.
Patrick Connor Johnson, MD,...
10/18/2021
Journal of Clinical Pathways
Daniel George, MD
Videos
Real-World Utilization of Advanced Therapies Among Patients With Metastatic CSPC
10/07/2021
Daniel George, MD, discusses results from a study analyzing real-world utilization of advanced therapies for patients with metastatic CSPC over time by metastatic site and age.
Daniel George, MD, discusses results from a study analyzing real-world utilization of advanced therapies for patients with metastatic CSPC over time by metastatic site and age.
Daniel George, MD, discusses...
10/07/2021
Journal of Clinical Pathways
David Tsui, MD
Videos
Real-World Adoption and Outcomes of Atezolizumab Plus Carboplatin and Etoposide for Extensive-Stage SCLC
10/04/2021
David Chun Cheong Tsui, MD, discusses results from a real-world study exploring the adoption and early clinical outcomes of atezolizumab plus carboplatin and etoposide in patients with extensive-stage SCLC.
David Chun Cheong Tsui, MD, discusses results from a real-world study exploring the adoption and early clinical outcomes of atezolizumab plus carboplatin and etoposide in patients with extensive-stage SCLC.
David Chun Cheong Tsui, MD,...
10/04/2021
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use